Evaluation of treatment response to niraparib in patients with platinum-sensitive recurrent ovarian cancer and measurable lesions at baseline: a sub-analysis of the phase III NORA trial-MedSci.cn - 梅斯（MedSci）

Evaluation of treatment response to niraparib in patients with platinum-sensitive recurrent ovarian cancer and measurable lesions at baseline: a sub-analysis of the phase III NORA trial

Yin, RT; Wu, XH; Zhu, JQ; Yang, JX; Deng, T; Wang, J; Wu, LY; Liu, ZL; Gao, YN; Wang, DB; Lou, G; Yang, HY; Zhou, Q; Kong, BH; Huang, Y; Chen, LP; Li, GL; An, RF; Wang, K; Zhang, Y; Yan, XJ; Lu, X; Wang, L; Tan, T; Dong, J

GYNECOLOGIC ONCOLOGY, 2021; 162 (): S154

科室
- - 订阅+
  - 更多科室
工具
服务